Envista Holdings Corp. (NVST)
22.90
-0.60
(-2.55%)
USD |
NYSE |
Oct 16, 16:00
22.91
+0.01
(+0.04%)
Pre-Market: 20:00
Envista Holdings Research and Development Expense (Annual) : 114.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 114.00M |
| December 31, 2024 | 99.10M |
| December 31, 2023 | 93.80M |
| December 31, 2022 | 100.10M |
| December 31, 2021 | 100.50M |
| Date | Value |
|---|---|
| December 31, 2020 | 86.70M |
| December 31, 2019 | 154.70M |
| December 31, 2018 | 172.00M |
| December 31, 2017 | 172.40M |
| December 31, 2016 | 142.80M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Dentsply Sirona, Inc. | 150.00M |
| Align Technology, Inc. | 369.91M |
| Milestone Scientific, Inc. | 0.4495M |
| Sonendo, Inc. | 4.269M |
| Abbott Laboratories | 2.889B |